{
    "organizations": [],
    "uuid": "7834816f72f043be0aa7a47895f57758d7a62b77",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-ptc-therapeutics-reports-q1-loss-p/brief-ptc-therapeutics-reports-q1-loss-per-share-0-46-idUSFWN1SG1J6",
    "ord_in_thread": 0,
    "title": "BRIEF-PTC Therapeutics Reports Q1 Loss Per Share $0.46",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 9 (Reuters) - PTC Therapeutics Inc:\n* PTC THERAPEUTICS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES A CORPORATE UPDATE\n* PTC THERAPEUTICS INC - TOTAL REVENUES FOR Q1 OF 2018 WERE $56.1 MILLION COMPARED TO $26.5 MILLION IN SAME PERIOD IN 2017\n* PTC THERAPEUTICS INC QTRLY LOSS PER SHARE $0.46 * PTC THERAPEUTICS INC - FULL YEAR 2018 NET PRODUCT REVENUES TO BE BETWEEN $260 AND $295 MILLION Source text for Eikon: Further company coverage:\n ",
    "published": "2018-05-10T04:12:00.000+03:00",
    "crawled": "2018-05-10T17:32:54.000+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "ptc",
        "therapeutic",
        "inc",
        "ptc",
        "therapeutic",
        "report",
        "first",
        "quarter",
        "financial",
        "result",
        "provides",
        "corporate",
        "update",
        "ptc",
        "therapeutic",
        "inc",
        "total",
        "revenue",
        "q1",
        "million",
        "compared",
        "million",
        "period",
        "ptc",
        "therapeutic",
        "inc",
        "qtrly",
        "loss",
        "per",
        "share",
        "ptc",
        "therapeutic",
        "inc",
        "full",
        "year",
        "net",
        "product",
        "revenue",
        "million",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}